Cambridge Healthtech Institute’s 13th Annual
Enrollment Planning and Patient Recruitment
Predicting and Improving Enrollment through Evidence, Data, New Tech and Creative Engagement
February 19-20, 2020
Patient recruitment and up-front enrollment planning are critical to drug development programs. Patient recruitment, if not adequately planned for, can extend your development timeline by a number of years. Retention of patients throughout the life of
a clinical trial is essential in order to have complete data sets for your analysis and subsequent filings. To optimize both, you have to have a plan and effectively leverage analytics and technology without losing site of the participant’s
user experience. One must take into account the needs of different patient populations, the importance of diversity, how to use digital tech, challenges of consent processes, direct-to-patient models, and many other factors. CHI’s 13th Annual
“Enrollment Planning and Patient Recruitment” will cover the topics one should consider when drafting and strategically implementing a patient recruitment plan for a patient-centric and inclusive clinical development program.
Stay on and attend Part 2 (Thurs-Fri): Patient Engagement, Enrollment and Retention through Communities and Technology
Day 1 | Day 2 | Download Brochure
Tuesday, February 18
9:00 am - 7:15 pm Registration Open
2:00 - 5:00 pm User Group Meetings
2:00 - 5:00 pm The NEW SCOPE China Clinical Development Partnering Forum and The NEW SCOPE Scientific
*Separate registration required. Must be a Best Value registered attendee.
5:00 - 6:20 pm Evening Kick-Off Plenary Keynote and Participant Engagement Awards
6:20 - 7:30 pm SCOPE’s Kick-Off Networking Happy Hour
(Co-Sponsorship Opportunities Available)
7:30 pm Close of Day
Wednesday, February 19
7:15 am Registration Open and Morning Coffee
8:15 Morning Opening Plenary Keynotes
9:40 Grand Opening Coffee Break in the Exhibit Hall
10:40 Chairperson’s Remarks
Diana Foster, PhD, CEO, Total Clinical Trial Management
10:45 Data and Diversity: The Need for Increased Representation across Clinical Trials
Charlotte Jones-Burton, MD, Vice President, Global Clinical Development, Otsuka Pharmaceutical Development & Commercialization, Inc.
Despite known differences in disease prevalence and therapy response across ethnicities and genders, women and minority groups have been historically underrepresented in clinical trials, limiting findings on response from the full breadth of potential
patients. How can we ensure that our commitment to addressing unmet need is reflected in complete, diverse patient datasets? The solution begins long before the first patient is enrolled in a trial. This talk will discuss the urgent need for increased
diversity within the clinical trials space at every level, from initial study design through final read-out.
11:15 The Intersection of Patients and Technology: Innovating Clinical Trials with Patients in Mind
Michelle Shogren, Director of Innovation, Pharma R&D Clinical Operations, Bayer
We are all working to design and execute truly patient-centered drug development and trials. At the same time we are onboarding a myriad of new technologies, from advanced analytics to wearables. So, how do you innovate while keeping the patient at the
center? This presentation will share examples of design thinking principals put to use when bringing in new technology and will suggest how we can set our new way of working up for success.
11:45 SPECIAL CASE STUDY: Operationalizing Patient-Centric Enrollment Using Digital Tech and Direct-to-Patient Models
Greg Hersch, PhD, Head, Innovation, Global Development Operation, Novartis
Medicines can spend years in the development pipeline held back by a lack of suitable patients at clinical sites, yet we know the patients exist and are desperately waiting for the right medicines. Digital approaches can transform recruiting by adopting
direct-to-patient models with these approaches, enabling access to a wider pool of potential patients and the ability to explore new responses to diseases. We will share our vision for an end-to-end clinical trial recruitment capability based on a
modular and partnership approach, and also highlight the problems and pitfalls that that can be encountered when developing Outreach Electronica.
12:15 pm Presentation to be Announced
12:45 Transition to Lunch
12:50 LUNCHEON PRESENTATION: The (Not So Distant) Future State of Patient Recruitment
Neil Weisman, President, Continuum Clinical
Join this fast-paced, inspiring presentation that will leave you feeling energized about the future of patient recruitment. Learn about how and when to start incorporating next-gen technology into your patient recruitment strategies.
1:20 Coffee and Dessert Break in the Exhibit Hall
2:15 Chairperson’s Remarks
Chair to be Announced, Clariness
2:20 Let’s Talk Options and Scalability: Exploring the Evolution of Patient-Centric Technologies in Clinical Trials
Hassan Kadhim, Director, Clinical Trial Business Capabilities, GCO, Bristol-Myers Squibb
Patient technology is proliferating at a fast pace in the healthcare industry, but it is still slow at scaling in the clinical research arena. This talk will explore strategies at scaling patient-centric technologies in clinical trials to enable wider
adoption while benefitting patients in the way they want to be engaged.
2:50 Presentation to be Announced
3:05 Patients are a Virtue: How to Find the Right Participants for Your Trial
Mark Joing, MBA, Vice President, Clinical Operations, Menlo Therapeutics Inc.
Leading patient recruitment experts and organizations are finding new ways to connect patients to trials and are tackling the thorniest of patient recruitment challenges. What hurdles do they have in common and what solutions are worth investing time
and money in? This talk will share qualitative research, consisting of interviews with leading patient recruitment experts, innovators, and service providers to understand the trends, latest tools, technologies, and other recent innovations impacting
the patient recruitment landscape. It will also share a simple yet powerful framework, called S4, as a tool for anyone looking to improve patient recruitment in any trial.
3:20 Supporting Clinical Trial Recruitment – Program versus Study Level
Melanie Goodwin, Director, Patient Recruitment Programs, Clinical Development & Operations, Pfizer
This presentation will discuss the pros and cons of supporting clinical trial enrollment efforts at the program level versus the study level. It will look at how operational and financial efficiencies are impacted, as well as the risks involved in these
3:50 Presentation to be Announced
4:20 Find Your Table and Meet Your Moderator
4:25 Interactive Breakout Discussion Groups
Concurrent breakout discussion groups are interactive, guided discussions hosted by a facilitator or set of co-facilitators to discuss key issues presented earlier in the day’s sessions. Delegates will join a table of interest and become an active
part of the discussion. Bring your pharma, biotech, CRO, site, hospital or patient perspective to each of the discussions. To get the most out of this interactive session and format, please come prepared to share examples from your work, vet some
ideas with your peers, be a part of group interrogation and problem solving, and most importantly, participate in active idea sharing.
5:10 Welcome Reception in the Exhibit Hall
6:45 Close of Day
Day 1 | Day 2 | Download Brochure
Thursday, February 20
7:15 am Registration Open
7:45 BREAKFAST PRESENTATION: Navigating the Patient Journey: A Responsibility all Technology Providers Share
Mike Nolte, Chief Executive Officer, Signant Health
8:15 Session Break
8:20 Chairperson’s Remarks
Chair to be Announced, WIRB Copernicus Group
8:25 The Trifecta Effect: Leveraging Perspectives from Sponsors, Physicians, and Patients for Clinical Trial Success
Aaron Fleishman, Director, Market Development and Expansion, BBK Worldwide
Study Voices returns to SCOPE 2020 as part of a BBK Worldwide’s ongoing commitment to shed light on key clinical research trends. Make your clinical trials more patient-centric by considering perspectives from sponsors, physicians, and patients.
Reduce the silos and common misperceptions by listening to their collective voices.
8:55 Engaging Patients in Digital Health Trials: Experiences from a Large Academic Health Center
Ramya Palacholla, MD, Lead Scientist, Partners HealthCare Pivot Labs
This presentation will provide an overview of some of the most common barriers to recruiting and retaining patients in digital health trials in addition to covering proven strategies for increasing patient engagement and retention in trials.
9:10 “Patients didn’t join my trial.” We asked 4,000 patients why
Laurent Schockmel, DVM, MBA, CEO, Antidote
Finding the right patients at the right time requires a deep understanding of the patient experience. This presentation will share results of a groundbreaking survey examining motivations for and barriers to participation in research, and dive into what
these findings mean for your recruitment strategies.
9:25 CO-PRESENTATION: Listening to Representative Patient Populations Matters: How Co-Creating with Patients Creates Better Outcomes
Cassandra Smith, MBA, Associate Director, Diversity and Inclusion in Clinical Trials Lead, Janssen R&D
Lauren Gadsby, MBA, Program Manager, Investigator and Patient Engagement, Janssen R&D
To improve enrollment of underserved and underrepresented populations in clinical trials and to ensure that all patients have access to innovative and high quality care regardless of race or ethnicity, it is important to actually ASK what patients need
so they feel comfortable joining a trial. Ensuring the patient population in a trial is representative of the actual incidence of the disease itself is vital to understand the impact on patient lives. We will share a case study, where we co-created
with patients and made significant changes to our approach in order to better deliver a better experience. We will also be able to share results as a result of asking, listening, and acting on what we learned.
9:55 Using Advanced Risk-Based Monitoring Models to Improve Endpoint Data Quality
Todd Everhart, Clinical Vice President, Internal Medicine, Signant Health
Combining clinical insights with data analytical approaches significantly enhances the ability of risk-based monitoring programs to detect anomalous data and improve signal detection. In this session, we will demonstrate the use of advanced risk-based
analytics to detect and prevent data quality issues such as fraud, compliance with protocol, procedure violations, site staff lacking knowledge of study instruments used, etc. with real-life data across a number of therapeutic area indications.
10:25 Coffee Break in the Exhibit Hall
11:20 Chairperson’s Remarks
Ivor Clarke, President & CEO, SubjectWell
11:25 Data-Driven Approach to Participant Recruitment
Charissa Barger, MS, Recruitment Specialist, Alzheimer’s Therapeutic Research Institute, Keck School of Medicine, USC
Using a data-driven approach, investigators can optimize recruitment activities and efficiently reach potential participants. This talk will discuss tools available to collect data on recruitment activities, including: google analytics, Facebook pixel,
trackable links and phone numbers and survey data. Evidence from the Alzheimer’s Disease Neuroimaging Initiative 3 (ADNI3) will be used as a model for a successful data-driven approach to participant recruitment.
11:55 How to Use RWD to Optimize Eligibility Criteria and Enhance Recruitment
Jack Sheehan, MBA, PhD, Director, Real-World Value and Evidence, Neuroscience, Janssen Scientific Affairs (JSA)
This presentation will outline best practices to leverage EHR and claims data for recruitment and eligibility in clinical trials. Attendees will learn about CTTI’s newly released recommendations that provide practical models and operational
guidance for the use of RWD to facilitate RCT planning and execution.
12:25 pm Transition to Lunch
12:30 BRIDGING LUNCHEON CO-PRESENTATION: Putting Patients & Caregivers First: An In-Depth Look at Strategic Partnerships in Executing a Successful Clinical Trial
Karen Renzi, Director, Strategy, Praxis Communications, LLC
Samantha Rogers, Patient Recruitment & Retention Lead, Takeda
Join us as we pull back the curtain to review strategies from a case study that highlights a patient-centric approach to drug development. We’ll discuss how to craft a strategic plan that resonates with both the patient and caregiver. This session
will focus on tactics that were successfully executed as well as mid-study adjustments that were implemented in order to optimize patient recruitment and retention.
1:00 Coffee and Dessert Break in the Exhibit Hall
2:00 Close of Conference
Stay on and attend Part 2: Patient Engagement, Enrollment and Retention through Communities and Technology
Day 1 | Day 2 | Download Brochure